Literature DB >> 18486468

Adjuvant chemotherapy after resection of liver metastases from colorectal cancer.

Irving Taylor1.   

Abstract

Colorectal liver metastases are common and found in almost 50% of patients with colorectal cancer. Surgical excision, whenever possible, is the optimum form of treatment and should be carried out with the intention of removing all macroscopic disease (R0 resection). However, recurrence frequently occurs within the remaining liver as well as at extra-hepatic sites. The role of adjuvant systemic chemotherapy in an attempt to reduce the incidence of recurrence has been investigated in several studies. This review discusses the possible incorporation of adjuvant systemic chemotherapy following liver resection.

Entities:  

Mesh:

Year:  2008        PMID: 18486468     DOI: 10.1016/j.ejca.2008.04.007

Source DB:  PubMed          Journal:  Eur J Cancer        ISSN: 0959-8049            Impact factor:   9.162


  2 in total

1.  A viscerally driven cachexia syndrome in patients with advanced colorectal cancer: contributions of organ and tumor mass to whole-body energy demands.

Authors:  Jessica R Lieffers; Marina Mourtzakis; Kevin D Hall; Linda J McCargar; Carla M M Prado; Vickie E Baracos
Journal:  Am J Clin Nutr       Date:  2009-02-25       Impact factor: 7.045

2.  Outcome of microscopic incomplete resection (R1) of colorectal liver metastases in the era of neoadjuvant chemotherapy.

Authors:  Ninos Ayez; Zarina S Lalmahomed; Alexander M M Eggermont; Jan N M Ijzermans; Jeroen de Jonge; Kees van Montfort; Cornelis Verhoef
Journal:  Ann Surg Oncol       Date:  2011-10-18       Impact factor: 5.344

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.